SMART Fundamentals, Video #4: Dr. Tyler Williamson presents “Appraising Pharmaceutical Safety Trials with ‘Confidence'” [21 min]

Welcome back to SMART Fundamentals. In this video module, Dr. Tyler Williamson, Associate Professor of Biostatistics at the University of Calgary, presents "Appraising Pharmaceutical Safety Trials with ‘Confidence’: Examining the Results and Methodology of the Oral Surveillance Safety Study". Assessing the safety of pharmaceutical products is an important part of all clinical trials. In this … Continue reading SMART Fundamentals, Video #4: Dr. Tyler Williamson presents “Appraising Pharmaceutical Safety Trials with ‘Confidence'” [21 min]

SMART Fundamentals, Video #3: Dr. Tyler Williamson discusses Multiple Testing – why it’s a problem and strategies to address it [25 min]

Welcome to SMART Fundamentals Episode 3. In this video module, Dr. Tyler Williamson, Associate Professor of Biostatistics at the University of Calgary, discusses Multiple Testing, when more than one statistical test is being conducted as part of a study. In this session we will discuss why multiple testing is a problem and and a few … Continue reading SMART Fundamentals, Video #3: Dr. Tyler Williamson discusses Multiple Testing – why it’s a problem and strategies to address it [25 min]

Issue #3 of “Rheuminate” is now out! We highlight new data on the long-term safety and efficacy of upadacitinib in RA, feature the autoimmune disease-related subset of the INBUILD trial in ILD with nintedanib, and review the impact of adding a multidisciplinary care billing code on access to rheumatology care in British Columbia.

Rheuminate is a monthly selection of new publications clinically relevant to the SMART community of Canadian rheumatologists. In this third issue, we consider the following topics: Long-term extension data for UPA vs ADA in RANintedanib for autoimmune disease-related interstitial lung diseaseMultidisciplinary care assessments at rheumatology clinics in BC >> Read Rheuminate Issue #3 here. View … Continue reading Issue #3 of “Rheuminate” is now out! We highlight new data on the long-term safety and efficacy of upadacitinib in RA, feature the autoimmune disease-related subset of the INBUILD trial in ILD with nintedanib, and review the impact of adding a multidisciplinary care billing code on access to rheumatology care in British Columbia.

Issue #2 of “Rheuminate” is now out! We CATCH up with some new data from the Canadian Early Arthritis Cohort, highlight a network meta-analysis that compares safety among the growing family of JAKi, and feature a comparative analysis of the relative benefits and risks of upadacitinib compared to adalimumab. Read Issue #2 here.

Rheuminate is a monthly selection of new publications clinically relevant to the SMART community of Canadian rheumatologists. In this second issue, we consider the following topics: Glucocorticoid use in the Canadian Early Arthritis CohortSystematic review and network meta-analysis of CV and VTE risk with JAKiComparative benefit-risk analysis of upadacitinib and adalimumab >> Read Rheuminate Issue … Continue reading Issue #2 of “Rheuminate” is now out! We CATCH up with some new data from the Canadian Early Arthritis Cohort, highlight a network meta-analysis that compares safety among the growing family of JAKi, and feature a comparative analysis of the relative benefits and risks of upadacitinib compared to adalimumab. Read Issue #2 here.

Introducing “Rheuminate”, a monthly feature of the SMART community where recent articles are selected and summarized for clinical relevance to Canadian rheumatologists. Read Issue #1 here.

We’re delighted to introduce a new feature of the SMART community – Rheuminate! Rheuminate is a monthly selection of new publications clinically relevant to the SMART community of Canadian rheumatologists. Rheuminate will be sent to all SMART members by email each month and included in the weekly SMART email digests. In this first issue, we … Continue reading Introducing “Rheuminate”, a monthly feature of the SMART community where recent articles are selected and summarized for clinical relevance to Canadian rheumatologists. Read Issue #1 here.

SMART Fundamentals, Video #2: Dr. Tyler Williamson presents a video overview of the SMART webinar on head-to-head trials held on May 19th, 2021

In this SMART Fundamentals module, Dr. Tyler Williamson (Associate Professor, Biostatistics, University of Calgary) provides a video summary of the material covered during the SMART webinar on head-to-head trials held on May 19th, 2021.  >> View the video [8 min] View archived SMART Fundamentals videos at smartrheum.org/fundamentals.

Introducing “SMART Fundamentals”, a new feature of the SMART community which reviews important topics in assessing clinical trials. In this first video, Dr. Shahin Jamal presents “Head-to-Head Trials”.

In this first video of the SMART Fundamentals series, Dr. Shahin Jamal reviews Head-to-Head Trials, assessing whether two possible treatment options can offer the same outcomes for your patients.  >> View the video [10 mins] View archived SMART Fundamentals videos at smartrheum.org/fundamentals.

Invitation: SMART Webinar on Head-to-Head Trials, May 19th, 2021 7:30 pm to 9:00 pm ET

You're invited to the SMART Webinar "Head-to-Head Trials" on Wednesday, May 19th, 2021 from 7:30 to 9:00 pm Eastern Time. Download PDF invitation at http://bit.ly/SMARTHead-to-HeadWebinarRegister at http://mpg-group.ca/en/head-to-head-trials Speakers: Louis Bessette, MD, MSc, FRCPCShahin Jamal, MD, FRCPC Jean-Pierre Raynauld, MD, FRCPC Learning Objectives: By the end of this meeting, participants will be better able to: Improve skills in … Continue reading Invitation: SMART Webinar on Head-to-Head Trials, May 19th, 2021 7:30 pm to 9:00 pm ET